enhanced by

Saturday, 21st November 2009

ProStrakan

ProStrakan US outlicensing buoys shares PROSTRAKAN shares hit a record high yesterday after the group announced its largest-ever drug outlicensing deal, earning it an immediate $10 million (£6.2m) payment, writes Hamish Rutherford.

Italy just the job for ProStrakan growth PROSTRAKAN, the fast-growing Borders pharmaceutical company, is establishing an office in Italy, the largest European market in which it does not yet have its own sales force.

Strong sales put ProStrakan on road to profit PROSTRAKAN has continued its march towards profitability, revealing a 40 per cent rise in sales in the first half of the year.

Drug approval edges ProStrakan towards profitability for first time SCOTTISH drugs company ProStrakan is expected to declare this week that it is just a few months from breaking into the black for the first time.

ProStrakan on route to profit as drug cleared

ProStrakan turns to Optos finance chief to fill void left by Garvey's departure

Cancer drugs a tonic for ProStrakan

ProStrakan asks for gel rethink

ProStrakan unveils new cash deals for Sancuso

ProStrakan confident of US approval for key drug

ProStrakan rejects merger offers as hungry biotechs hunt out cash

ProStrakan shares surge on US test results for key cancer drug

ProStrakan wins £27m boost for US plans

ProStrakan plans US drugs trials

ProStrakan chemo treatment set to net £3m

Sales deal

ProStraken enters Nordic joint venture

ProStrakan gets first milestone payment from ProSkelia sale

ProStrakan first-half earnings jump 28%

ProStrakan's new sales team targets Italy

ProStrakan's high hopes for new male menopause 'cure'

ProStrakan shares fall on results delay

Drug discovery sale sees Prostrakan scoop £30m

1 2
Displaying page 1 of 2

Next » Last »

Include [3]

Include [2]

Include [1]

Include [6]

Include [5]

Include [4]

Include [9]

Include [8]

Include [7]

Home Back to content Sitemap Contact Us

Jobs

Search for a job

Keywords:

Job of the day:

Motors

Property

Featured Advertising

Johnston Press Digital Publishing

Sister Newspapers:

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.

Sections

Other Sections

Topics

Other Sites

ProStrakan

More Stories

Search for a job

Search for a car

Search for a house